Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung

Clinical trial NCT03808662 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03808662
Sponsor: Memorial Sloan Kettering Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

TNBC - Triple-Negative Breast Cancer Triple Negative Breast Cancer NSCLC NSCLC Stage IV Non Small Cell Lung Cancer Non Small Cell Lung Cancer Metastatic NSCLC Stage IV Without EGFR/ALK Mutation

Start date: 2019-01-16
Primary completion: 2027-01-01
Enrollment: 107

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.